PharmaCyte Biotech, Inc.
Common Stock · NASDAQ
Live TMS charts are coming soon.
Paper trading. Simulated, no real money.
No public theses on PMCB yet. When TMS traders open paper trades on it and make their thesis public, the long and short split, average conviction and hit rate show here.
Key stats load once market data is connected.
PharmaCyte Biotech filed an 8-K reporting that it entered into a material definitive agreement and completed an acquisition or disposition of assets. The filing headline gives no further detail on the deal's terms or counterparty.
No SEC financials for PMCB yet. Companies that file 10-K and 10-Q reports show revenue, earnings, cash flow and the balance sheet here.
Source: SEC filings (10-K, 10-Q).
Paper trading only. Nothing here is financial advice.